Announced in May 2025, the Dyno Frontiers Program helps gene therapy innovators prove the therapeutic potential of their ...

Dyno Therapeutics unveils best-in-class Dyno-bn8 AAV vector for muscle gene therapies, achieving therapeutic delivery with improved safety potential ...

While Dyno Nobel may have posted a $53 million loss in the 2024-25 financial year, it might all be worth it because the ...